What do systematic reviews say?

25 questions · 25 findings · 9 reviews · Heart

Sort:Best matchNewest Highest certainty Download CSV

No studies found 25 · 100%GRADE not reported 0 · 0%Very low 0 · 0%Low 0 · 0%Moderate 0 · 0%High 0 · 0%

Class I antiarrhythmics vs control

All‐cause mortality · Human trial participants undergoing ablation for atrial fibrillation

The review found no eligible studies for this question.

1 finding from 1 review

Oral Class I and III antiarrhythmic drugs for maintaining sinus rhythm after catheter ablation of atrial fibrillation 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Effects of high‐ vs low‐added sugar consumption

All‐cause mortality · Adults without diabetes or CVD

The review found no eligible studies for this question.

1 finding from 1 review

High versus low‐added sugar consumption for the primary prevention of cardiovascular disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

All‐cause mortality · healthy normal weighted participants recruited through leaflets from Italy

The review found no eligible studies for this question.

1 finding from 1 review

Effects of a gluten‐reduced or gluten‐free diet for the primary prevention of cardiovascular disease 2022 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IF vs CER (short term)

All‐cause mortality · the prevention of cardiovascular disease

The review found no eligible studies for this question.

1 finding from 1 review

Intermittent fasting for the prevention of cardiovascular disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IF vs CER (medium term)

All‐cause mortality · the prevention of cardiovascular disease

The review found no eligible studies for this question.

1 finding from 1 review

Intermittent fasting for the prevention of cardiovascular disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

IF vs ad libitum (short term)

All‐cause mortality · the prevention of cardiovascular disease

The review found no eligible studies for this question.

1 finding from 1 review

Intermittent fasting for the prevention of cardiovascular disease 2021 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Milrinone vs dobutamine

All‐cause mortality · adults with low cardiac output syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Enoximone vs piroximone

All‐cause mortality · adults with low cardiac output syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Enoximone vs epinephrine‐nitroglycerine

All‐cause mortality · adults with low cardiac output syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Flecainide vs placebo or no treatment

All‐cause mortality · adults in sinus rhythm after cardioversion of atrial fibrillation

The review found no eligible studies for this question.

1 finding from 1 review

Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs propafenone

All‐cause mortality · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs amiodarone

All‐cause mortality · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs dimethylammonium

All‐cause mortality · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs aprindine

All‐cause mortality · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Lidocaine vs pirmenol

All‐cause mortality · patients with myocardial infarction

The review found no eligible studies for this question.

1 finding from 1 review

Prophylactic lidocaine for myocardial infarction 2015 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dopexamine vs dopamine

All‐cause long‐term mortality · adults with low cardiac output syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Enoximone vs dobutamine

All‐cause long‐term mortality · adults with low cardiac output syndrome

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Dopamine‐milrinone vs dopamine‐dobutamine

All‐cause long‐term mortality · adults with cardiogenic shock

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Levosimendan vs enoximone

All‐cause long‐term mortality · adults with cardiogenic shock

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Epinephrine vs norepinephrine‐dobutamine

All‐cause long‐term mortality · adults with cardiogenic shock

The review found no eligible studies for this question.

1 finding from 1 review

Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found